References
- JablenskyASchizophrenia: recent epidemiologic issuesEpidemiol Rev199517110208521927
- Ascher-SvanumHZhuBFariesDEThe cost of relapse and the predictors of relapse in the treatment of schizophreniaBMC Psychiatry2010101220059765
- MangaloreRKnappMCost of schizophrenia in EnglandJ Ment Health Policy Econ2007101234117417045
- BuchananRWKreyenbuhlJKellyDLSchizophrenia Patient Outcomes Research Team (PORT)The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsSchizophr Bull2010361719319955390
- Ayuso-GutiérrezJLdel Río VegaJMFactors influencing relapse in the long-term course of schizophreniaSchizophr Res1997282–31992069468354
- LevanderSJensenJGråweRTuningerESchizophrenia – progressive and massive decline in response readiness by episodesActa Psychiatr Scand Suppl2001104408657411730075
- AndreasenNCLiuDZiebellSVoraAHoBCRelapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI studyAm J Psychiatry2013170660961523558429
- GoffDCHillMFreudenreichOStrategies for improving treatment adherence in schizophrenia and schizoaffective disorderJ Clin Psychiatry201071suppl 2202621190649
- BodénRBrandtLKielerHAndersenMReutforsJEarly non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorderSchizophr Res20111331–3364121982098
- VerdouxHLengronneJLiraudFMedication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjectsActa Psychiatr Scand2000102320321011008856
- MorkenGWidenJHGraweRWNon-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophreniaBMC Psychiatry2008813218447935
- World Health OrganizationAdherence to Long-Term Therapies: Evidence for Action Section I – Setting the SceneGenevaWorld Health Organization2003116 Available from: http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdfAccessed November 23, 2014
- GilesJSocial science lines up its biggest challengesNature20114707332181921293348
- HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHPInterventions to enhance medication adherenceCochrane Database Syst Rev20054CD00001116235271
- LacroJPDunnLBDolderCRLeckbandSGJesteDVPrevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literatureJ Clin Psychiatry2002631089290912416599
- VelliganDILamYWGlahnDCDefining and assessing adherence to oral antipsychotics: a review of the literatureSchizophr Bull200632472474216707778
- World Health OrganizationAdherence to Long-Term Therapies: Evidence for Action Section II – Improving Adherence Rates: Guidance for CountriesGenevaWorld Health Organization20031744 Available from: http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdfAccessed November 23, 2014
- KempRKirovGEverittBHaywardPDavidARandomised controlled trial of compliance therapy. 18-month follow-upBr J Psychiatry199817254134199747403
- DolderCRLacroJPLeckbandSJesteDVInterventions to improve antipsychotic medication adherence: review of recent literatureJ Clin Psychopharmacol200323438939912920416
- BeckEMCaveltiMKvrgicSKleimBVauthRAre we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medicationSchizophr Res20111321424921820875
- KeithSJKaneJMPartial compliance and patient consequences in schizophrenia: our patients can do betterJ Clin Psychiatry200364111308131514658944
- BoczkowskiJAZeichnerADeSantoNNeuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome reportJ Consult Clin Psychol19855356666712865281
- LibermanRPWallaceCJBlackwellGKopelowiczAVaccaroJVMintzJSkills training versus psychosocial occupational therapy for persons with persistent schizophreniaAm J Psychiatry19981558108710919699698
- SchulzKFAltmanDGMoherDCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsJ Pharmacol Pharmacother20101210010721350618
- VelliganDIWeidenPJSajatovicMAdherence Problems in Patients with Serious and Persistent Mental IllnessJ Clin Psychiatry200970suppl 414819686636
- KaneJMLeuchtSCarpenterDDochertyJPExpert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic DisordersThe expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summaryJ Clin Psychiatry200364suppl 1251914640142
- HiemkeCBaumannPLauxGKussHJTherapeutisches Drug-Monitoring in der Psychiatrie. Konsensus-Leitlinie der AGNPPsychopharmakotherapie200512166182
- BortzJFormulierung und Überprüfung von HypothesenBortzJStatistik für Sozialwissenschaftler5th edBerlinSpringer Verlag1999 German
- BortzJLienertGABoehnkeKAnalyse von RangdatenBortzJLienertGABoehnkeKVerteilungsfreie Methoden in der Biostatistik2nd edBerlinSpringer Verlag2000197294 German
- BortzJLienertGABoehnkeKAnalyse von HäufigkeitenBortzJLienertGABoehnkeKVerteilungsfreie Methoden in der Biostatistik2nd edBerlinSpringer Verlag200087190 German
- ArnstenJHDemasPAFarzadeganHAntiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringClin Infect Dis20013381417142311550118
- BuelowJMSmithMCMedication management by the person with epilepsy: perception versus realityEpilepsy Behav20045340140615145311
- ZitoJMRouttWWMitchellJERoerigJLClinical characteristics of hospitalized psychotic patients who refuse antipsychotic drug therapyAm J Psychiatry198514278228262861754
- McEvoyJPFreterSEverettGInsight and the clinical outcome of schizophrenic patientsJ Nerv Ment Dis1989177148512535871
- OlfsonMMechanicDHansellSBoyerCAWalkupJWeidenPJPredicting medication noncompliance after hospital discharge among patients with schizophreniaPsychiatr Serv200051221622210655006